proline and Benign Monoclonal Gammopathies

proline has been researched along with Benign Monoclonal Gammopathies in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Anderson, KC; Arcaini, L; Brown, JR; Cao, Y; Greco, A; Hunter, ZR; Lindeman, NI; Liu, X; Manning, RJ; Morra, E; Munshi, NC; Patterson, CJ; Tai, YT; Treon, SP; Tripsas, CK; Trojani, A; Varettoni, M; Xu, L; Yang, G; Zhou, Y	1
Arcaini, L; Bonfichi, M; Boveri, E; Cazzola, M; Corso, A; Croci, G; Fiaccadori, V; Gotti, M; Guerrera, ML; Mangiacavalli, S; Morello, L; Orlandi, E; Pascutto, C; Paulli, M; Rattotti, S; Riboni, R; Varettoni, M; Zibellini, S	1

Other Studies

2 other study(ies) available for proline and Benign Monoclonal Gammopathies

Article	Year
MYD88 L265P in Waldenström macroglobulinemia, immunoglobulin M monoclonal gammopathy, and other B-cell lymphoproliferative disorders using conventional and quantitative allele-specific polymerase chain reaction. Blood, 2013, Mar-14, Volume: 121, Issue:11 Topics: Adult; Aged; Alleles; Amino Acid Substitution; B-Lymphocytes; Base Sequence; Case-Control Studies; Cell Transformation, Neoplastic; DNA Mutational Analysis; Humans; Immunoglobulin M; Leucine; Lymphoproliferative Disorders; Male; Middle Aged; Molecular Sequence Data; Monoclonal Gammopathy of Undetermined Significance; Myeloid Differentiation Factor 88; Polymerase Chain Reaction; Polymorphism, Single Nucleotide; Proline; Waldenstrom Macroglobulinemia	2013
Prevalence and clinical significance of the MYD88 (L265P) somatic mutation in Waldenstrom's macroglobulinemia and related lymphoid neoplasms. Blood, 2013, Mar-28, Volume: 121, Issue:13 Topics: Adult; Aged; Aged, 80 and over; Amino Acid Substitution; Case-Control Studies; Female; Humans; Immunoglobulin M; Leucine; Lymphoma; Lymphoproliferative Disorders; Male; Middle Aged; Monoclonal Gammopathy of Undetermined Significance; Mutation, Missense; Myeloid Differentiation Factor 88; Prevalence; Proline; Waldenstrom Macroglobulinemia	2013

Article

Year

MYD88 L265P in Waldenström macroglobulinemia, immunoglobulin M monoclonal gammopathy, and other B-cell lymphoproliferative disorders using conventional and quantitative allele-specific polymerase chain reaction.

Blood, 2013, Mar-14, Volume: 121, Issue:11

Topics: Adult; Aged; Alleles; Amino Acid Substitution; B-Lymphocytes; Base Sequence; Case-Control Studies; Cell Transformation, Neoplastic; DNA Mutational Analysis; Humans; Immunoglobulin M; Leucine; Lymphoproliferative Disorders; Male; Middle Aged; Molecular Sequence Data; Monoclonal Gammopathy of Undetermined Significance; Myeloid Differentiation Factor 88; Polymerase Chain Reaction; Polymorphism, Single Nucleotide; Proline; Waldenstrom Macroglobulinemia

2013

Prevalence and clinical significance of the MYD88 (L265P) somatic mutation in Waldenstrom's macroglobulinemia and related lymphoid neoplasms.

Blood, 2013, Mar-28, Volume: 121, Issue:13

Topics: Adult; Aged; Aged, 80 and over; Amino Acid Substitution; Case-Control Studies; Female; Humans; Immunoglobulin M; Leucine; Lymphoma; Lymphoproliferative Disorders; Male; Middle Aged; Monoclonal Gammopathy of Undetermined Significance; Mutation, Missense; Myeloid Differentiation Factor 88; Prevalence; Proline; Waldenstrom Macroglobulinemia

2013